CVS HEALTH Corp
CVSUnited States
79 filed reports · 853 financial concepts · 42 earnings calls · 10 media appearances
Filed reports
79 reports · Jun 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 167 operating metrics, 215 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 38 | 192 | Dec 2017 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 31 | 8,058 | Jun 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 8,273 | Dec 2016 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 5, 2026 | 6 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 556 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 6, 2026 | 4 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 343 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 10, 2026 | 1,691 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 10, 2026 | 4 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 29, 2025 | 3 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 29, 2025 | 473 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 31, 2025 | 273 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 31, 2025 | 3 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 1, 2025 | 274 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 1, 2025 | 2 | Open |
Financial data
853 concepts · 16,523 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial771 concepts · 13,454 facts · Dec 2012 to Jul 2026
- Supporting experience-rated products268 · Jun 2019 to Dec 2025
- Treasury shares held in trust (in shares)67 · Dec 2016 to Jun 2026
- Cash and cash equivalents at carrying value58 · Dec 2014 to Jun 2026
- Net income loss58 · Dec 2014 to Jun 2026
- Operating income loss58 · Dec 2014 to Jun 2026
- Revenue58 · Dec 2014 to Jun 2026
- Comprehensive income net of tax57 · Dec 2014 to Jun 2026
- Comprehensive income net of tax including portion attributable to noncontrolling interest57 · Dec 2014 to Jun 2026
- Income tax expense benefit57 · Dec 2014 to Jun 2026
- Net income loss attributable to noncontrolling interest57 · Dec 2014 to Jun 2026
- Other comprehensive income loss net of tax57 · Dec 2014 to Jun 2026
- Profit loss57 · Dec 2014 to Jun 2026
- Common stock dividends per share declared56 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable56 · Dec 2014 to Jun 2026
- Increase decrease in accounts receivable56 · Dec 2014 to Jun 2026
- Increase decrease in inventories56 · Dec 2014 to Jun 2026
- Increase decrease in other operating assets56 · Dec 2014 to Jun 2026
- Increase decrease in other operating liabilities56 · Dec 2014 to Jun 2026
- Net cash provided by used in financing activities56 · Dec 2014 to Jun 2026
- Net cash provided by used in investing activities56 · Dec 2014 to Jun 2026
- Net cash provided by used in operating activities56 · Dec 2014 to Jun 2026
- Payments of dividends56 · Dec 2014 to Jun 2026
- Payments to acquire businesses net of cash acquired56 · Dec 2014 to Jun 2026
- Payments to acquire property plant and equipment56 · Dec 2014 to Jun 2026
Segment47 concepts · 2,112 facts · Dec 2014 to Jun 2026
- Operating Segments628 · Dec 2016 to Jun 2026
- Revenue482 · Dec 2014 to Jun 2026
- Net investment income171 · Dec 2016 to Jun 2026
- Health Care Benefits94 · Dec 2018 to Jun 2026
- Depreciation depletion and amortization82 · Dec 2016 to Jun 2026
- Goodwill65 · Dec 2015 to Dec 2025
- Cost of goods and services sold (US GAAP)64 · Dec 2016 to Jun 2026
- Revenue (excluding assessed tax)64 · Dec 2017 to Dec 2023
- Operating income loss58 · Dec 2014 to Dec 2018
- Policyholder benefits and claims incurred net48 · Dec 2016 to Jun 2026
- Realized investment gains losses42 · Dec 2022 to Jun 2026
- Segment reporting other item amount36 · Dec 2022 to Dec 2025
- Gross profit (US GAAP)27 · Dec 2014 to Sep 2018
- Operating expenses (US GAAP)25 · Dec 2016 to Sep 2018
- Goodwill impairment loss24 · Jun 2017 to Dec 2025
- Property plant and equipment additions22 · Dec 2014 to Dec 2019
- Goodwill acquired during period18 · Dec 2015 to Dec 2023
- Pharmacy Services Segment18 · Dec 2014 to Sep 2018
- Gross Profit14 · Jun 2015 to Sep 2018
- Operating Income14 · Jun 2015 to Sep 2018
- Retail/ LTC13 · Dec 2017 to Dec 2021
- Goodwill written off related to sale of business unit12 · Dec 2018 to Dec 2025
- Policyholder benefits and claims incurred health care12 · Mar 2018 to Sep 2018
- Revenue from contracts with customers (excluding tax)9 · Dec 2016 to Sep 2019
Product22 concepts · 675 facts · Dec 2016 to Jun 2026
- Revenue161 · Dec 2016 to Jun 2026
- Operating Segments136 · Dec 2018 to Jun 2026
- Liability for future policy benefit expected future policy benefit interest expense40 · Mar 2022 to Dec 2025
- Liability for future policy benefit expected future policy benefit issuance40 · Mar 2022 to Dec 2025
- Liability for future policy benefits payment for benefits40 · Mar 2022 to Dec 2025
- Investment income net34 · Mar 2018 to Sep 2024
- Liability for unpaid claims and claims adjustment expense claims paid current year124 · Dec 2018 to Sep 2023
- Liability for unpaid claims and claims adjustment expense claims paid prior years124 · Dec 2018 to Sep 2023
- Liability for unpaid claims and claims adjustment expense incurred claims124 · Dec 2018 to Sep 2023
- Payments for losses and loss adjustment expense24 · Dec 2018 to Sep 2023
- Supplemental information for property casualty insurance underwriters current year claims and claims adjustment expense24 · Dec 2018 to Sep 2023
- Supplemental information for property casualty insurance underwriters prior year claims and claims adjustment expense24 · Dec 2018 to Sep 2023
- Liability for future policy benefit expected net premium interest income20 · Mar 2022 to Dec 2025
- Liability for future policy benefit expected net premium net premium collected20 · Mar 2022 to Dec 2025
- Liability for unpaid claims and claims adjustment expense business acquisitions20 · Dec 2018 to Sep 2023
- Total premium deficiency reserve5 · Sep 2024 to Jun 2026
- Premium deficiency reserve, charge to health care costs4 · Sep 2024 to Mar 2025
- Health Insurance Product Line3 · Dec 2018 to Dec 2020
- Premium deficiency reserve, charge of unamortized acquisition costs3 · Sep 2024 to Mar 2025
- Available for sale securities gross unrealized gains2 · Dec 2018 to Mar 2019
- Available for sale securities gross unrealized loss2 · Dec 2018 to Mar 2019
- Medicaid Product Line1 · Jun 2026
Guidance10 concepts · 159 facts · Jan 2018 to Aug 2026
- EPS (Diluted) Guidance82 · May 2018 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))31 · Aug 2018 to Aug 2026
- Operating Income Growth Guidance16 · Jan 2018 to Nov 2018
- Operating Income Guidance12 · Feb 2019 to Jan 2023
- Operating Income Growth Guidance (Adjusted (non-GAAP))4 · Aug 2018
- Operating Income Guidance (Adjusted (non-GAAP))4 · May 2019 to Feb 2020
- Revenue Guidance4 · Jan 2023 to Aug 2026
- Effective Tax Rate Guidance2 · Jan 2018
- Free Cash Flow Guidance2 · Nov 2018
- Revenue Growth Guidance2 · Jan 2018
KPI3 concepts · 123 facts · Jun 2017 to Jun 2026
- Comparable Sales Growth88 · Dec 2017 to Jun 2026
- Store Count18 · Jun 2017 to Jun 2026
- People Served17 · Dec 2018 to Jun 2026
Segments
2,787 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments17 members · 2,112 facts
- Health Care Benefits511 · Dec 2016 to Jun 2026
- Pharmacy Services366 · Dec 2014 to Dec 2022
- Retail Long Term Care288 · Dec 2016 to Dec 2022
- Health Services241 · Dec 2021 to Jun 2026
- Pharmacy And Consumer Health240 · Dec 2021 to Jun 2026
- Corporate And Other218 · Dec 2016 to Jun 2026
- Retail ltcsegment67 · Jun 2015 to Sep 2018
- Corporate50 · Dec 2014 to Sep 2018
- Pharmacy services segment34 · Dec 2015 to Dec 2022
- Health care benefits segment33 · Mar 2018 to Dec 2025
- Retail long term care segment25 · Dec 2017 to Dec 2022
- Corporate and other14 · Sep 2022 to Mar 2026
- Health services segment8 · Dec 2022 to Dec 2025
- Pharmacy and consumer health segment8 · Dec 2022 to Dec 2025
- Rx Crossroads6 · Jun 2017 to Dec 2017
- Ltcreporting unit2 · Jun 2018 to Sep 2018
- LTC Reporting Unit1 · Jun 2018
Product or servicesrt:ProductOrServiceAxis14 members · 651 facts
- Health Insurance Product Line167 · Dec 2018 to Sep 2023
- Long Term Care100 · Mar 2022 to Dec 2025
- Large Case Pensions60 · Mar 2022 to Dec 2025
- Front Store Revenue47 · Mar 2018 to Jun 2026
- Pharmacy Revenue47 · Mar 2018 to Jun 2026
- Premiums47 · Mar 2018 to Jun 2026
- Product And Service Other47 · Mar 2018 to Jun 2026
- Product43 · Dec 2017 to Jun 2026
- Service43 · Dec 2017 to Jun 2026
- Supporting Experience Rated Products37 · Mar 2018 to Sep 2024
- Individual Exchange Product Line6 · Sep 2024 to Mar 2025
- Medicaid Product Line3 · Sep 2024 to Jun 2026
- Medicare Product Line3 · Sep 2024
- Group Medicare Advantage Product Line1 · Jun 2025
Product or serviceus-gaap:ProductOrServiceAxis8 members · 24 facts
- Front Store Revenue5 · Mar 2018 to Dec 2018
- Pharmacy Revenue5 · Mar 2018 to Dec 2018
- Other Revenue3 · Mar 2018 to Sep 2018
- Premiums3 · Dec 2016 to Dec 2018
- Product3 · Dec 2016 to Dec 2018
- Service3 · Dec 2016 to Dec 2018
- Product And Service Other1 · Dec 2018
- Supporting Discontinued And Experience Rated Products1 · Dec 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary155 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary190 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes14 claims from 1 reports · Dec 2025
- Risk factors87 risks from 2 annual reports · 2024 to 2025
Earnings calls
42 calls · May 2016 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2026 Q1May 6, 2026
- FY2025 Q4Feb 10, 2026
- FY2025 Q3Oct 29, 2025
- FY2025 Q2Jul 31, 2025
- FY2025 Q1May 1, 2025
- FY2024 Q4Feb 12, 2025
- FY2024 Q3Nov 6, 2024
- FY2024 Q2Aug 7, 2024
- FY2024 Q1May 1, 2024
- FY2023 Q4Feb 7, 2024
- FY2023 Q3Nov 1, 2023
- FY2023 Q2Aug 2, 2023
- FY2023 Q1May 3, 2023
- FY2022 Q4Feb 8, 2023
- FY2022 Q3Nov 2, 2022
Executive media
10 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances5 · Jan 2026 to Jul 2026
- TV interviews3 · Aug 2019 to Dec 2025
- Hearing2 · Jan 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.